ZNF460 and malignant colon neoplasm: ZNF460 overexpression was significantly associated with poor prognosis and increased metastatic capabilities of human colon cancer by activating JAK2/STAT3 signaling pathway, and ZNF460 might act as a potential prognostic biomarker and therapeutic target.